Unlocking the Potential of ATP1A3: A Drug Target for Na+, K+-Activated Adenosine Triphosphatase Alpha Subunit

Target Name: ATP1A3

NCBI ID: G478

ATP1A3

Unlocking the Potential of ATP1A3: A Drug Target for Na+, K+-Activated Adenosine Triphosphatase Alpha Subunit

ATP (adenosine triphosphate) is a crucial molecule in various cellular processes, including intracellular signaling, neurotransmission, and muscle contractions. The Na+, K+-activated adenosine triphosphatase (ATP1A3) alpha subunit, a protein that plays a key role in regulating ATP production, has recently been identified as a potential drug target or biomarker. In this article, we will explore the biology of ATP1A3, its functions, and the potential implications for drug development.

Biochemistry and Functions of ATP1A3

ATP1A3 is a member of the A subunit of the ATP synthase enzyme, a complex that catalyzes the production of ATP from ADP and phosphate ions. The Na+, K+-activated adenosine triphosphatase alpha subunit functions as a critical regulatory unit for ATP production, as it controls the rate at which ATP is produced and degraded.

ATP1A3 is composed of 125 amino acid residues and has a calculated molecular mass of 19,312 Daltons. The protein is expressed in various tissues and cells, including heart, brain, liver, and muscle. It is highly conserved across species, with only minor differences in its sequence and structure.

In cellular signaling, ATP1A3 plays a crucial role in intracellular signaling, as it is involved in the regulation of various signaling pathways, including DNA replication, gene expression, and cell survival. ATP1A3 has been shown to be involved in the regulation of DNA replication, as it has been shown to interact with the DNA-binding protein, p53.

In neurotransmission, ATP1A3 is involved in the regulation of synaptic plasticity and learning. The protein has been shown to play a role in the regulation of neurotransmitter release and synaptic plasticity, as well as in the modulation of neural circuits.

In muscle contractions, ATP1A3 is involved in the regulation of muscle force production and relaxation. The protein has been shown to play a role in the regulation of muscle contractions and muscle relaxation, as well as in the modulation of muscle sensitivity to external stimuli.

Drug Development and ATP1A3 as a Potential Biomarker

The identification of ATP1A3 as a potential drug target or biomarker has significant implications for the development of new therapeutic strategies. By inhibiting the activity of ATP1A3, researchers may be able to treat various diseases and disorders that are characterized by the overproduction or underproduction of ATP.

One of the key challenges in the development of new treatments for ATP-related diseases is the development of specific and effective inhibitors of ATP1A3. To address this challenge, researchers have used a variety of techniques to design and optimize novel ATP1A3 inhibitors. These efforts have led to the development of various compounds, including small molecules, peptides, and antibodies.

In addition to its potential as a drug, ATP1A3 has also been identified as a potential biomarker for various diseases. The protein is expressed in various tissues and cells and can be used as a marker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

In conclusion, ATP1A3 is a protein that plays a critical role in the regulation of ATP production and has significant implications for the development of new therapeutic strategies. The identification of ATP1A3 as a potential drug target or biomarker has significant implications for the development of new treatments for various diseases. Further research is needed to fully understand the biology of ATP1A3 and to develop effective inhibitors of the protein.

Protein Name: ATPase Na+/K+ Transporting Subunit Alpha 3

Functions: This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients

The "ATP1A3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP1A3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets